NUDT21 siRNA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NUDT21 siRNA, covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma [EARLY_Phase 1]